About
Basic Data Updated:
14 days agoHemogenomics Private Limited was founded with a noble mission – to prevent the spread of HIV and hepatitis through infected blood. The company is dedicated to providing blood transfusion services, with a focus on ensuring the safety of donated blood. In partnership with Grifols (formerly Novartis Diagnostics), Hemogenomics offers Individual Donor Nucleic Acid Testing (ID-NAT) to screen donated blood for potential infections. Since its inception in 2002, Hemogenomics has established itself as a trusted name in the healthcare industry. Its clientele includes prestigious institutions such as Indraprastha Apollo Hospital, Artemis Hospital, Armed Forces Transfusion Centre, Rotary Blood Bank, KEM Hospital, and Mahatma Gandhi Hospital. These partnerships are a testament to the company's commitm... Read More
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
| CIN/LLPIN/FCRN | U73100KA2002PTC030032 |
| Company No. | 030032 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 22 Jan 2002 |
| Date of AGM | 27 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Bangalore |
Products or Services related to Hemogenomics Private Limited
Corona Test Kit
Financials of Hemogenomics Private Limited
Hemogenomics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.09% increase. The company also saw a substantial fall in profitability, with a 19.27% decrease in profit. The company's net worth moved up by a moderate rise of 5.86%.
Enhance accessibility to Hemogenomics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Hemogenomics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Hemogenomics Private Limited
Unlock and access historical data on people associated with Hemogenomics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (1)
SB
Sumit Bagaria
Managing DirectorAppointment Date: 18-Jan-2011
Status: Current
Board Members(2)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 02 Mar 2016 | ₹5.00 Cr | Open |
Citi Bank N.A. Creation Date: 11 Jan 2012 | ₹35.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hemogenomics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hemogenomics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
10 years 4 months 
Recent activity within the organization
Annual General Meeting
Hemogenomics Private Limited last Annual general meeting of members was held on 27 Sep 2023 as per latest MCA records.
27 Sep 2023Balance Sheet
Hemogenomics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.
31 Mar 2023Charges
A charge with Citi Bank N.A. of Rs. 35.00 cr registered on 11 Jan 2012 with Charge ID 10337103 was modified on 15 Feb 2022.
15 Feb 2022Charges
A charge with Citi Bank N.A. amounted to Rs. 5.00 cr with Charge ID 100019339 was registered on 02 Mar 2016.
02 Mar 2016Charges
A charge with Citi Bank N.A. amounted to Rs. 35.00 cr with Charge ID 10337103 was registered on 11 Jan 2012.
11 Jan 2012
Frequently asked questions
What is the Incorporation or founding date of Hemogenomics Private Limited?